NYSE: JEF

Jefferies Financial Group Inc.

CIK 0000096223 · SIC 6211 · Security Brokers & Dealers

Mega Revenue $10.8B Assets $79.5B as of Oct 4, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (TLRY 10-Q) is open in full — no account needed.

10-Q Filed Oct 9, 2026 · Period ending Aug 31, 2026

Jefferies' net earnings attributable to common shareholders rose 26.7% to $283.9M in the fiscal third quarter, including a goodwill impairment of $58.2 million related to Tessellis.

5 material changes detected. Sign up free to read the summary.

424B5 Filed Sep 30, 2026 Red flag

Jefferies Financial Group prices $1,000 senior autocallable notes linked to worst-performing of three indices

5 material changes detected. Sign up free to read the summary.

Partner

Trade JEF commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

424B5 Filed Sep 30, 2026 Red flag

Jefferies to issue senior autocallable contingent coupon notes linked to worst-performing of three indices; terms preliminary

5 material changes detected. Sign up free to read the summary.

424B5 Filed Sep 30, 2026 Red flag

Jefferies Financial Group prices $1,000-per-note autocallable contingent coupon notes linked to worst-performing of three indices

5 material changes detected. Sign up free to read the summary.

8-K Filed Sep 28, 2026 · Period ending Sep 28, 2026

Summary not yet generated.

424B5 Filed Jul 21, 2026

Summary not yet generated.

424B5 Filed Jul 21, 2026

Summary not yet generated.

8-K Filed Jul 15, 2026 · Period ending Jul 15, 2026

Jefferies closes €850M senior notes offering due 2033 at 4.500%

2 material changes detected. Sign up free to read the summary.

10-Q Filed Jul 9, 2026 · Period ending May 31, 2026 Standing risk

revenue $3.12B, net income $250.0M. Q2 revenue +25.0% on record advisory; (27.6M ×; filing rounds to (27.6M ×; filing rounds to (27.6M ×; filing rounds to ))) equity offering completed

5 material changes detected. Sign up free to read the summary.

424B5 Filed Jul 9, 2026

Summary not yet generated.

8-K Filed Jul 8, 2026 · Period ending Jul 8, 2026

Jefferies prices €850M senior notes at 4.500%, due 2033, settling July 15

3 material changes detected. Sign up free to read the summary.

424B5 Filed Jul 7, 2026

Summary not yet generated.

424B5 Filed Jul 2, 2026 Red flag

Jefferies Financial Group prices $1.21 billion structured notes linked to worst performer of EEM and SX5E; investors lose 1% per 1% decline below 30% threshold, up to 100% loss

5 material changes detected. Sign up free to read the summary.

424B5 Filed Jul 2, 2026 Red flag

Jefferies Financial Group prices structured notes linked to worst-performing of three equity indices

5 material changes detected. Sign up free to read the summary.

424B5 Filed Jul 2, 2026

Jefferies prices 3.5-year structured notes linked to EURO STOXX 50 with 155% upside leverage, 1-to-1 downside below 75% threshold

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 24, 2026 · Period ending Jun 24, 2026

Jefferies reports record Q2 investment banking and equities revenues, $1.02 EPS, 12.8% ROAE

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 28, 2026 · Period ending Apr 23, 2026

Summary not yet generated.

8-K Filed Apr 24, 2026 · Period ending Apr 23, 2026

Summary not yet generated.

424B3 Filed Apr 16, 2026

Summary not yet generated.

10-Q Filed Apr 7, 2026 · Period ending Feb 28, 2026

Summary not yet generated.

8-K Filed Mar 31, 2026 · Period ending Mar 26, 2026

Summary not yet generated.

10-K Filed Jan 28, 2026 · Period ending Nov 30, 2025

Summary not yet generated.

10-Q Filed Oct 9, 2025 · Period ending Aug 31, 2025

Summary not yet generated.

10-Q Filed Jul 9, 2025 · Period ending May 31, 2025

Summary not yet generated.

10-K Filed Jan 28, 2025 · Period ending Nov 30, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 9, 2026 (period ending Aug 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Earnings (Unaudited)

$ in thousands

Description Three months ended August 31, 2026 Three months ended August 31, 2025 Nine months ended August 31, 2026 Nine months ended August 31, 2025
Revenues
Investment banking 1,303,833 1,088,197 3,531,742 2,606,976
Principal transactions 468,655 486,893 1,444,819 1,232,630
Commissions and other fees 392,932 325,178 1,161,150 966,711
Asset management fees and revenues 9,869 13,079 87,019 118,563
Interest 922,999 846,894 2,590,080 2,570,090
Other 132,510 147,433 405,450 379,883
Total revenues 3,230,798 2,907,674 9,220,260 7,874,853
Interest expense 1,008,864 860,242 2,774,745 2,599,955
Net revenues 2,221,934 2,047,432 6,445,515 5,274,898
Non-interest expenses
Compensation and benefits 1,192,745 1,083,510 3,466,880 2,779,476
Brokerage and clearing fees 139,475 121,164 420,053 360,345
Underwriting costs 31,858 20,332 90,099 52,703
Technology and communications 173,235 157,171 495,953 442,844
Occupancy and equipment rental 34,713 32,908 103,072 93,818
Business development 83,000 78,999 247,530 231,360
Professional services 88,652 73,329 264,303 223,563
Depreciation and amortization 43,282 53,230 147,475 136,471
Cost of sales 22,922 34,430 84,095 118,959
Other expenses 61,014 60,544 247,252 217,578
Total non-interest expenses 1,870,896 1,715,617 5,566,712 4,657,117
Earnings before income taxes 351,038 331,815 878,803 617,781
Income tax expense 62,785 89,311 181,226 147,033
Net earnings 288,253 242,504 697,577 470,748
Net losses attributable to noncontrolling interests (2,740) (10,041) (24,038) (24,692)
Preferred stock dividends 7,110 28,559 59,897 55,528
Net earnings attributable to common shareholders 283,883 223,986 661,718 439,912
Earnings per voting common share (1)
Basic 1.22 1.04 2.99 2.05
Diluted 1.18 1.01 2.88 1.98
Basic weighted-average common shares outstanding 198,437 215,293 208,132 214,977
Diluted weighted-average common shares outstanding 206,345 222,715 215,531 222,539
Earnings per non-voting common share (1)
Basic 1.35 — 3.53 —
Diluted 1.23 — 3.06 —
Basic weighted-average common shares outstanding 30,293 — 11,353 —
Diluted weighted-average common shares outstanding 38,981 — 32,624 —

Consolidated Statements of Financial Condition (Unaudited)

$ in thousands

Description August 31, 2026 November 30, 2025
Assets
Cash and cash equivalents 16,883,584 14,043,889
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations 1,177,954 917,697
Financial instruments owned, at fair value (includes securities pledged of $17,552,721 and $17,419,373) 27,282,633 27,722,739
Investments in and loans to related parties 1,653,340 1,496,125
Securities borrowed 11,158,355 8,295,161
Securities purchased under agreements to resell 7,840,742 8,449,107
Securities received as collateral, at fair value 289,869 200,495
Receivables:
Brokers, dealers and clearing organizations 3,096,144 4,310,143
Customers 4,416,818 3,439,921
Fees, interest and other 877,248 806,324
Premises and equipment 1,193,043 1,246,470
Goodwill 1,726,023 1,837,570
Assets held for sale 294,060 —
Other assets (includes assets pledged of $675,462 and $627,259) 3,412,045 3,246,706
Total assets 81,301,858 76,012,347
Liabilities and Equity
Short-term borrowings 1,465,781 1,767,206
Financial instruments sold, not yet purchased, at fair value 15,095,989 13,320,152
Securities loaned 4,023,003 2,540,759
Securities sold under agreements to repurchase 12,920,669 12,156,737
Other secured financings (includes $413,121 and $425,964 at fair value) 2,336,070 2,885,878
Obligation to return securities received as collateral, at fair value 289,869 200,495
Payables:
Brokers, dealers and clearing organizations 5,182,459 6,955,100
Customers 6,175,387 5,216,714
Lease liabilities 541,486 594,097
Liabilities held for sale 302,551 —
Accrued expenses and other liabilities 3,756,749 3,836,709
Long-term debt (includes $3,941,920 and $3,734,843 at fair value) 18,458,995 15,895,891
Total liabilities 70,549,008 65,369,738
Mezzanine Equity
Redeemable noncontrolling interests 406 406
Equity
Series B preferred shares, par value of $1 per share, authorized 70,000 shares; 0 and 55,125 shares issued and outstanding — 55
Voting common shares, par value $1 per share, authorized 552,264,500 and 565,000,000 shares; 189,078,660 and 206,296,167 shares issued and outstanding, after deducting 132,039,410 and 114,821,903 shares held in treasury 189,079 206,296
Non-voting common shares, par value $1 per share, authorized 47,735,500 and 35,000,000, shares; 40,579,081 and 0 shares issued and outstanding 40,579 —
Additional paid-in capital 1,850,209 2,177,954
Accumulated other comprehensive loss (361,922) (384,434)
Retained earnings 8,996,409 8,574,825
Total Jefferies Financial Group Inc. shareholders' equity 10,714,354 10,574,696
Noncontrolling interests 38,090 67,507
Total equity 10,752,444 10,642,203
Total liabilities and equity 81,301,858 76,012,347

Consolidated Statements of Cash Flows (Unaudited)

$ in thousands

Description Nine months ended August 31, 2026 Nine months ended August 31, 2025
Cash flows from operating activities:
Net earnings 697,577 470,748
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization 128,699 144,434
Impairment of assets 65,413 —
Share-based compensation 95,767 67,810
Net bad debt expense 30,583 16,931
Income on investments in and loans to related parties (99,082) (54,270)
Distributions received on investments in related parties 52,400 71,368
Loss on assets held for sale — 12,566
Other adjustments 47,095 434,110
Net change in assets and liabilities:
Receivables:
Brokers, dealers and clearing organizations 1,210,771 (193,514)
Customers (976,898) (533,734)
Fees, interest and other (116,742) (60,040)
Securities borrowed (2,867,877) (945,232)
Financial instruments owned 416,562 (1,712,385)
Securities purchased under agreements to resell 597,100 (1,664,568)
Other assets (95,054) (266,563)
Payables:
Brokers, dealers and clearing organizations (1,769,291) (26,372)
Customers 958,673 374,518
Securities loaned 1,486,559 (62,979)
Financial instruments sold, not yet purchased 1,792,713 1,260,915
Securities sold under agreements to repurchase 771,786 (312,049)
Lease liabilities (58,788) (48,280)
Accrued expenses and other liabilities 85,540 (432,723)
Net cash provided by (used in) operating activities 2,453,506 (3,459,309)
Cash flows from investing activities:
Contributions to investments in and loans to related parties (766,395) (466,338)
Capital distributions from investments and repayments of loans from related parties 593,556 379,193
Originations and purchases of loans, notes and other receivables (24,782) —
Principal collections of loans, notes and other receivables 156 —
Net payments on premises and equipment (162,203) (151,425)
Proceeds from assets held for sale — 26,843
Net cash used in investing activities (359,668) (211,727)
Cash flows from financing activities:
Proceeds from short-term borrowings 5,211,712 7,170,583
Payments on short-term borrowings (5,497,779) (6,363,688)
Proceeds from issuance of long-term debt, net of issuance costs 6,968,788 3,852,721
Repayment of long-term debt (4,397,648) (1,758,422)
Purchase of common shares for treasury (439,932) (58,486)
Dividends paid to common and preferred shareholders (276,460) (280,589)
Net proceeds from (payments on) other secured financings (539,583) 497,768
Net change in bank overdrafts (10,278) (22,050)
Proceeds from contributions of noncontrolling interests 981 18,909
Payments on distributions to noncontrolling interests (7,606) (8,084)
Other 17,470 9,573
Net cash provided by financing activities 1,029,665 3,058,235
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,566) 17,281
Change in cash, cash equivalents, and restricted cash reclassified from (to) assets held for sale (20,985) —
Net increase (decrease) in cash, cash equivalents, and restricted cash 3,120,937 (595,520)
Cash, cash equivalents, and restricted cash at beginning of period 14,961,586 13,165,612
Cash, cash equivalents, and restricted cash at end of period 18,061,538 12,570,092

Amounts as printed on the EDGAR/iXBRL face — $ in thousands. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing